These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 451491)

  • 1. Skin collagen biosynthesis in patients with rheumatoid arthritis treated with D-penicillamine.
    Schorn D; Francis MJ; Loudon M; Mowat AG
    Scand J Rheumatol; 1979; 8(2):124-8. PubMed ID: 451491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine in rheumatoid arthritis. Connective tissue changes and alterations in serum copper and phase reactants in relation to clinical improvement.
    Hansen TM; Manthorpe R; Kofod B; Andreassen T; Oxlund H; Lorenzen IB
    J Rheumatol; 1976 Dec; 3(4):367-74. PubMed ID: 1022870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the growth and metabolism of cells cultured from normal, sclerotic and rheumatoid connective tissue brought about by D-penicillamine and by sodium salicylate.
    Priestley GC
    J Invest Dermatol; 1980 Jun; 74(6):413-7. PubMed ID: 6445922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine in rheumatoid arthritis: wound healing, skin thickness and osteoporosis.
    Schorn D; Mowat AG
    Rheumatol Rehabil; 1977 Nov; 16(4):223-30. PubMed ID: 601432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the collagen of synovial membrane in rheumatoid arthritis and effect of D-penicillamine.
    Lovell CR; Nicholls AC; Jayson MI; Bailey AJ
    Clin Sci Mol Med; 1978 Jul; 55(1):31-40. PubMed ID: 352601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
    Davis P; Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of D-penicillamine for the treatment of rheumatoid arthritis and the study of various mechanisms of its action].
    Trofimova TM; Panasiuk AF; Avdeeva ZhI; Tarasenkova TA; Astakhova TA
    Ter Arkh; 1980; 52(6):110-3. PubMed ID: 7404375
    [No Abstract]   [Full Text] [Related]  

  • 8. Penicillamine treatment in rheumatoid arthritis. A retrospective study.
    Börjesson O; Knutsson LP; Svensson B
    Acta Med Scand; 1980; 207(1-2):93-6. PubMed ID: 7368979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
    Rosenbaum J; Katz WA; Schumacher HR
    Ann Rheum Dis; 1980 Apr; 39(2):152-4. PubMed ID: 7387219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.
    Thomas D; Gallus AS; Brooks PM; Tampi R; Geddes R; Hill W
    Ann Rheum Dis; 1984 Jun; 43(3):402-6. PubMed ID: 6742902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D(-) penicillamine on polymeric structural collagen of skin.
    Francis MJ; Mowat AG; Smith R
    Lancet; 1973 Apr; 1(7806):773-4. PubMed ID: 4120751
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of D-penicillamine on collagen biosynthesis by fibroblast cell cultures.
    Chamson A; Frey J
    Clin Exp Pharmacol Physiol; 1985; 12(6):549-55. PubMed ID: 3835038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine.
    Uitto J; Helin P; Rasmussen O; Lorenzen I
    Ann Clin Res; 1970 Sep; 2(3):228-34. PubMed ID: 5473163
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatment.
    Kang SS; Wong PW; Glickman PB; MacLeod CM; Jaffe IA
    J Clin Pharmacol; 1986; 26(8):712-5. PubMed ID: 3793964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
    Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
    Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collagenolytic enzymes of the skin in chronic polyarthritis - transformations during D-penicillamin therapy].
    Kolarz G; Braun F; Menzel J; Scherak O
    Z Rheumatol; 1981; 40(1):37-9. PubMed ID: 7223081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis.
    Mbuyi-Muamba JM; Dequeker J
    Clin Rheumatol; 1983 Dec; 2(4):369-74. PubMed ID: 6678197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J
    Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of penicillamine on human collagen and its possible application to treatment of scleroderma.
    Harris ED; Sjoerdsma A
    Lancet; 1966 Nov; 2(7471):996-9. PubMed ID: 4162669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.